Kewaunee Scientific 2026: Revenue $66.32M, EPS $0.58— 10-Q Summary
Займёт меньше минуты
Kewaunee Scientific reported results for the quarter ended 2026 with revenue of $66.32M and diluted EPS of $0.58, as demand in domestic lab construction softened versus the prior-year quarter.
Financial Highlights
| Metric | Current quarter | Prior year quarter | YoY change |
| Revenue¹ | $66.32M | $71.1M | (6.7%) |
| Net income² | $1.71M | $3.09M | (44.8%) |
| Diluted EPS³ | $0.58 | $1.04 | (44.2%) |
¹ Reported as “Net sales”. ² Reported as “Net earnings attributable to Kewaunee Scientific Corporation”. ³ Reported as “Diluted earnings per share attributable to Kewaunee Scientific Corporation stockholders”.
Business Highlights
- Revenue decline driven by weaker domestic lab construction demand; overall sales fell to $66.32M from $71.10M a year earlier.
- Channel mix: LPG segment down 6.4% and international sales down 7.8%, with softness in India partially offset by strength in APAC.
- Gross margin improved to 29.6%, supported by stronger margins in the International segment and operational improvements.
- Order backlog stood at $169M versus $205M in the prior-year period; company is focused on converting high quoting activity into awards through commercial and operational initiatives.
Original SEC Filing: KEWAUNEE SCIENTIFIC CORP /DE/ [ KEQU ] - 10-Q - Sep. 11, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.